Subscribe to RSS
DOI: 10.1055/s-0029-1217542
An Efficient Synthesis of Functionalized 6,10-Dioxo-6,10-dihydro-5H-pyrido[1,2-a]quinoxalines and 6,10-Dioxo-6,10-dihydropyrido[2,1-c][1,4]benzoxazines
Publication History
Publication Date:
03 July 2009 (online)
Abstract
An efficient synthesis of alkyl 8-hydroxy-6,10-dioxo-6,10-dihydro-5H-pyrido[1,2-a]quinoxaline-7-carboxylates and alkyl 8-hydroxy-6,10-dioxo-6,10-dihydropyrido[2,1-c][1,4]benzoxazine-7-carboxylates is described. This involves the reaction between malonyl dichloride and alkyl 2-[3,4-dihydro-3-oxoquinoxaline 2(1H)-ylidene]acetates or alkyl 2-(2-oxo-2H-benzo[b][1,4]oxazin-3(4H)-ylidene)acetates in CH2Cl2 at room temperature.
Key words
malonyl dichloride - pyrido[1,2-a]quinoxaline - pyrido[2,1-c][1,4]benzoxazine - benzene-1,2-diamine - 2-aminophenol - acetylenic ester
- 1
Lindsley CW.Zhao Z.Leister WH.Robinson RG.Barnett SF.Defeo-Jones D.Jones RE.Hartman GD.Huff JR.Huber HE.Duggan ME. Bioorg. Med. Chem. Lett. 2005, 15: 761 - 2
Loriga M.Piras S.Sanna P.Paglietti G. Farmaco 1997, 52: 157 - 3
Seitz LE.Suling WJ.Reynolds RC. J. Med. Chem. 2002, 45: 5604 - 4
He W.Meyers MR.Hanney B.Spada A.Blider G.Galzeinski H.Amin D.Needle S.Page K.Jayyosi Z.Perrone H. Bioorg. Med. Chem. Lett. 2003, 13: 3097 - 5
Kim YB.Kim YH.Park JY.Kim SK. Bioorg. Med. Chem. Lett. 2004, 14: 541 - 6
Sonawane ND.Rangnekar DW. J. Heterocycl. Chem. 2002, 39: 303 - 7
Katoh A.Yoshida T.Ohkanda J. Heterocycles 2000, 52: 911 - 8
Dailey S.Feast JW.Peace RJ.Sage IC.Till S.Wood EL. J. Mater. Chem. 2001, 11: 2238 - 9
O’Brien D.Weaver MS.Lidzey DG.Bradley DDC. Appl. Phys. Lett. 1996, 69: 881 - 10
Bailly C.Echepare S.Gago F.Waring M. Anti-Cancer Drug Des. 1999, 14: 291 - 11
Raw SA.Wilfred CD.Taylor RJK. Chem. Commun. 2003, 18: 2286 - 12
Gilchrist TL. Heterocyclic Chemistry 2nd ed.: Wiley and Sons; New York: 1992. p.272-276 - 13
Taylor EC.Maryanoff CA.Skotnickilc JS. J. Org. Chem. 1980, 45: 2513 - 14
Yavari I.Souri S.Sirouspour M. Synlett 2008, 1633 - 15
Yavari I.Souri S. Synlett 2007, 2969 - 16
Yavari I.Souri S. Synlett 2008, 1208 - 18
Yavari I.Mirzaie A.Moradi L. Helv. Chim. Acta 2006, 89: 2825 - 19
Yavari I.Shaabani A.Soliemani H.Nourmohammadian F.Bijanzadeh H. Magn. Reson. Chem. 1996, 34: 1003 - 20
Kappe T.Linnau Y.Stadlbauer W. Monatsh. Chem. 1977, 108: 103
References and Notes
General Procedure
for the Synthesis of Compounds 4
To a suspension of 3 (2 mmol)
[¹8]
in
CH2Cl2 (10 mL) was added of malonyl dichloride
(0.29 g, 2.1 mmol) at r.t. The reaction mixture was then stirred
for 15 min. The formed precipitate was filtered off and washed with
CH2Cl2 to afford the pure product.
Compound 4a:
pale yellow powder; mp 300-304 ˚C (dec.); yield
0.56 g (98%). IR (KBr): νmax = 3450,
1729, 1693, 1655, 1490, 1418, 1365, 1306, 1258, 1106, 757 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 3.74
(3 H, s, OMe), 6.08 (1 H, s, CH), 7.12 (1 H, d, ³
J = 7.8 Hz,
CH), 7.20 (1 H, t, ³
J = 7.9
Hz, CH), 7.30 (1 H, t, ³
J = 8.0
Hz, CH), 9.19 (1 H, d, ³
J = 7.8
Hz, CH), 11.76 (1 H, s, OH), 11.84 (1 H, s, NH) ppm. ¹³C
NMR (125.7 MHz, CDCl3): δ = 52.6
(OMe), 102.9 (CH), 112.4 (C), 116.4 (CH), 121.5 (CH), 122.8 (CH),
123.9 (C), 127.3 (CH), 128.1 (C), 133.0 (C), 156.2 (COH), 162.1
(CO), 162.9 (CO), 165.3 (CO2) ppm. MS: m/z (%) = 285
(20) [M - 1+], 262
(20), 236 (35), 179 (10), 123 (40), 97 (50), 83 (55), 69 (60), 57
(100), 43 (90). Anal. Calcd (%) for C14H10N2O5 (286.24):
C, 58.75; H, 3.52; N, 9.79. Found: C, 58.60; H, 3.44; N, 9.65.
Compound 4d:
pale yellow powder; mp 298-300 ˚C (dec.); yield
0.55 g (97%). IR (KBr) νmax = 3505,
1764, 1721, 1661, 1618, 1499, 1408, 1333, 1304, 1294, 1106, 759
cm-¹. ¹H NMR (500
MHz, CDCl3): δ = 3.79
(3 H, s, OMe), 6.12 (1 H, s, CH), 7.27 (1 H, t, ³
J = 7.0 Hz,
CH), 7.30 (1 H, d, ³
J = 7.9 Hz,
CH), 7.33 (1 H, t, ³
J = 8.0
Hz, CH), 9.18 (1 H, d, ³
J = 8.6 Hz,
CH), 12.01 (1 H, s, OH) ppm.¹³C NMR
(125.7 MHz, CDCl3): δ = 52.5
(OMe), 104.1 (CH), 114.8 (C), 116.8 (CH), 120.6 (CH), 123.1 (C),
124.3 (CH), 127.0 (CH), 127.9 (C), 141.1 (C), 154.2 (COH), 161.4
(CO), 161.5 (CO), 164.1 (CO2) ppm. Anal. Calcd (%)
for C14H9NO6 (287.22): C, 58.54;
H, 3.16; N, 4.88. Found: C, 58.60; H, 3.14; N, 4.85.
Compound 4g: yellow powder; mp 298-301 ˚C
(dec.); yield 0.58 g (98%). IR (KBr) νmax = 3440,
1764, 1722, 1665, 1621, 1455, 1324, 1286, 1250, 1107, 765 cm-¹. ¹H
NMR (500 MHz, CDCl3): δ = 2.32
(3 H, s, Me), 3.78 (3 H, s, OMe), 6.10 (1 H, s, CH), 7.15 (1 H,
d, ³
J = 8.3
Hz, CH), 7.19 (1 H, d, ³
J = 8.3
Hz), 9.03 (1 H, s, CH), 11.99 (1 H, s, OH) ppm. ¹³C
NMR (125.7 MHz, CDCl3): δ = 20.9
(Me), 52.4 (OMe), 104.1 (CH), 114.8 (C), 116.5 (CH), 120.7 (CH),
122.6 (C), 127.4 (CH), 127.9 (C), 133.5 (C), 139.0 (C), 154.3 (C-OH), 161.3
(CO), 161.4 (CO), 164.1 (CO2) ppm. Anal. Calcd (%) for
C15H11NO6 (301.25): C, 59.81; H,
3.68; N, 4.65. Found: C, 59.80; H, 3.65; N, 4.65.
All
other novel compounds isolated possessed spectroscopic and analytical
data in keeping with their proposed structures.